Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.

Abstract

BACKGROUND Isoniazid is the standard medication used to treat latent tuberculosis infection (LTBI). The lengthy treatment with isoniazid, its perceived hepatotoxicity, and the increasing influx of foreign-born persons from countries with a higher prevalence of isoniazid resistance have compromised this regimen. In 2000, the Centers for Disease Control and… (More)

Topics

Cite this paper

@article{Lardizabal2006EnhancementOT, title={Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.}, author={Alfred A. Lardizabal and Marian Rose Passannante and Faysal Kojakali and Christopher Hayden and Lee B. Reichman}, journal={Chest}, year={2006}, volume={130 6}, pages={1712-7} }